Skip to main content
Erschienen in: European Journal of Nutrition 4/2020

31.05.2019 | Original Contribution

Vitamin B6 intake and incidence of diabetic retinopathy in Japanese patients with type 2 diabetes: analysis of data from the Japan Diabetes Complications Study (JDCS)

verfasst von: Chika Horikawa, Rei Aida, Chiemi Kamada, Kazuya Fujihara, Shiro Tanaka, Sachiko Tanaka, Atsushi Araki, Yukio Yoshimura, Tatsumi Moriya, Yasuo Akanuma, Hirohito Sone, Japan Diabetes Complications Study Group

Erschienen in: European Journal of Nutrition | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Although vitamin B6 has been suspected to prevent the progression of diabetic retinopathy, evidence of this in patients with type 2 diabetes based on longitudinal studies is sparse. This study investigated the relationship between vitamin B6 intake and the incidence of diabetic retinopathy in Japanese patients with type 2 diabetes.

Methods

The study was part of an examination of a nationwide cohort of patients with type 2 diabetes aged 40–70 years with HbA1c ≥ 48 mmol/mol. After excluding nonresponders to a dietary survey using the Food Frequency Questionnaire based on food groups, 978 patients were analyzed. Primary outcome was the 8-year risk of a diabetic retinopathy event, and Cox regression analyses estimated hazard ratios (HRs) for retinopathy according to vitamin B6 intake adjusted for age, gender, body mass index, HbA1c, smoking, energy intake, and other confounders.

Results

Mean vitamin B6 intake in quartiles ranged from 1.1 to 1.6 mg/day, and half of the participants had vitamin B6 intake below the recommended daily dietary allowance according to dietary reference intakes in Japanese adults (men 1.4 mg/day; women 1.2 mg/day). After adjusting for confounders, HRs for diabetic retinopathy in the 2nd, 3rd, and 4th quartile groups of vitamin B6 intake compared with the 1st quartile group were 1.17 (95% confidence interval 0.81–1.69, p = 0.403), 0.88 (0.58–1.34, p = 0.550), and 0.50 (0.30–0.85, p = 0.010), respectively.

Conclusions

Findings suggested that high vitamin B6 intake was associated with a lower incidence of diabetic retinopathy in Japanese with type 2 diabetes.
Literatur
1.
Zurück zum Zitat Satyanarayana A, Balakrishna N, Pitla S et al (2011) Status of B-vitamins and homocysteine in diabetic retinopathy: association with vitamin-B12 deficiency and hyperhomocysteinemia. PLoS ONE 6:e26747CrossRef Satyanarayana A, Balakrishna N, Pitla S et al (2011) Status of B-vitamins and homocysteine in diabetic retinopathy: association with vitamin-B12 deficiency and hyperhomocysteinemia. PLoS ONE 6:e26747CrossRef
2.
Zurück zum Zitat Fotiou P, Raptis A, Apergis G et al (2014) Vitamin status as a determinant of serum homocysteine concentration in type 2 diabetic retinopathy. J Diabetes Res 2014:807209CrossRef Fotiou P, Raptis A, Apergis G et al (2014) Vitamin status as a determinant of serum homocysteine concentration in type 2 diabetic retinopathy. J Diabetes Res 2014:807209CrossRef
3.
Zurück zum Zitat Ren X, Sun H, Zhang C et al (2016) Protective function of pyridoxamine on retinal photoreceptor cells via activation of the p-Erk1/2/Nrf2/Trx/ASK1 signalling pathway in diabetic mice. Mol Med Rep 14:420–424CrossRef Ren X, Sun H, Zhang C et al (2016) Protective function of pyridoxamine on retinal photoreceptor cells via activation of the p-Erk1/2/Nrf2/Trx/ASK1 signalling pathway in diabetic mice. Mol Med Rep 14:420–424CrossRef
4.
Zurück zum Zitat Yamagishi S, Matsui T, Nakamura K et al (2007) Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats. Ophthalmic Res 39:92–97CrossRef Yamagishi S, Matsui T, Nakamura K et al (2007) Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats. Ophthalmic Res 39:92–97CrossRef
5.
Zurück zum Zitat Stitt A, Gardiner TA, Alderson NL et al (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51:2826–2832CrossRef Stitt A, Gardiner TA, Alderson NL et al (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51:2826–2832CrossRef
6.
Zurück zum Zitat Graham IM, Daly LE, Refsum HM, Robinson K (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277:1775–1781CrossRef Graham IM, Daly LE, Refsum HM, Robinson K (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277:1775–1781CrossRef
7.
Zurück zum Zitat Brazoins L, Rowley K, Itsiopoulos K, Harper CA, O’Dea K (2008) Homocysteine and diabetic retinopathy. Diabetes Care 31:50–56CrossRef Brazoins L, Rowley K, Itsiopoulos K, Harper CA, O’Dea K (2008) Homocysteine and diabetic retinopathy. Diabetes Care 31:50–56CrossRef
8.
Zurück zum Zitat Tsai JC, Perrella MA, Yoshizumi M et al (1994) Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 91:6369–6373CrossRef Tsai JC, Perrella MA, Yoshizumi M et al (1994) Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 91:6369–6373CrossRef
9.
Zurück zum Zitat Lai WK, Kan MY (2015) Homocysteine-induced endothelial dysfunction. Ann Nutr Metab 67:1–12CrossRef Lai WK, Kan MY (2015) Homocysteine-induced endothelial dysfunction. Ann Nutr Metab 67:1–12CrossRef
10.
Zurück zum Zitat Diaz-Arrastia R (2000) Homocysteine and neurologic disease. Arch Neurol 57:1422–1427PubMed Diaz-Arrastia R (2000) Homocysteine and neurologic disease. Arch Neurol 57:1422–1427PubMed
11.
Zurück zum Zitat Voet Donald, Voet Judith G (2010) Biochemistry, 4th edn. Wiley, Hoboken Voet Donald, Voet Judith G (2010) Biochemistry, 4th edn. Wiley, Hoboken
12.
Zurück zum Zitat Erdman JW Jr, Macdonald IA, Zeisel SH (2012) Present knowledge in nutrition, 10th edn. Wiley-Blackwell, HobokenCrossRef Erdman JW Jr, Macdonald IA, Zeisel SH (2012) Present knowledge in nutrition, 10th edn. Wiley-Blackwell, HobokenCrossRef
13.
Zurück zum Zitat Sofi F, Marcucci R, Bolli P et al (2008) Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. Atherosclerosis 198:223–227CrossRef Sofi F, Marcucci R, Bolli P et al (2008) Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. Atherosclerosis 198:223–227CrossRef
14.
Zurück zum Zitat Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98–107CrossRef Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98–107CrossRef
15.
Zurück zum Zitat American Diabetes Association (2019) 11. Microvascular complications and foot care: standards of medical care in diabetes-2019. Diabetes Care 42:S124–S138CrossRef American Diabetes Association (2019) 11. Microvascular complications and foot care: standards of medical care in diabetes-2019. Diabetes Care 42:S124–S138CrossRef
16.
Zurück zum Zitat Ueland PM, Ulvik A, Rios-Avila L et al (2015) Direct and functional biomarkers of vitamin B6 status. Annu Rev Nutr 35:33–70CrossRef Ueland PM, Ulvik A, Rios-Avila L et al (2015) Direct and functional biomarkers of vitamin B6 status. Annu Rev Nutr 35:33–70CrossRef
17.
Zurück zum Zitat Ulvik A, Midttun Ø, Pedersen ER et al (2014) Evidence for increased catabolism of vitamin B-6 during systemic inflammation. Am J Clin Nutr 100:250–255CrossRef Ulvik A, Midttun Ø, Pedersen ER et al (2014) Evidence for increased catabolism of vitamin B-6 during systemic inflammation. Am J Clin Nutr 100:250–255CrossRef
18.
Zurück zum Zitat Sone H, Tanaka S, Iimuro S et al (2010) Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study). Diabetologia 53:419–428CrossRef Sone H, Tanaka S, Iimuro S et al (2010) Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study). Diabetologia 53:419–428CrossRef
19.
Zurück zum Zitat Tanaka S, Tanaka S, Iimuro S et al (2014) Cohort Profile: the Japan Diabetes Complications Study: a long-term follow-up of a randomised lifestyle intervention study of type 2 diabetes. Int J Epidemiol 43:1054–1062CrossRef Tanaka S, Tanaka S, Iimuro S et al (2014) Cohort Profile: the Japan Diabetes Complications Study: a long-term follow-up of a randomised lifestyle intervention study of type 2 diabetes. Int J Epidemiol 43:1054–1062CrossRef
20.
Zurück zum Zitat Wilkinson CP, Ferris FL 3rd, Klein RE et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682CrossRef Wilkinson CP, Ferris FL 3rd, Klein RE et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682CrossRef
21.
Zurück zum Zitat Takahashi K, Yoshimura Y, Kaimoto T et al (2001) Validation of a Food Frequency Questionnaire based on food groups for estimating individual nutrient intake. Jpn J Nutr 59:221–232CrossRef Takahashi K, Yoshimura Y, Kaimoto T et al (2001) Validation of a Food Frequency Questionnaire based on food groups for estimating individual nutrient intake. Jpn J Nutr 59:221–232CrossRef
24.
Zurück zum Zitat Jain SK, Lim G (2001) Pyridoxine and pyridoxamine inhibits superoxide radicals and prevents lipid peroxidation, protein glycosylation, and (Na2+ K+)-ATPaseactivity reduction in high glucose-treated human erythrocytes. Free Radic BiolMed 30:232–237CrossRef Jain SK, Lim G (2001) Pyridoxine and pyridoxamine inhibits superoxide radicals and prevents lipid peroxidation, protein glycosylation, and (Na2+ K+)-ATPaseactivity reduction in high glucose-treated human erythrocytes. Free Radic BiolMed 30:232–237CrossRef
25.
Zurück zum Zitat Charvet CD, Saadane A, Wang M et al (2013) Pretreatment with pyridoxamine mitigates isolevuglandin-associated retinal effects in mice exposed to bright light. J Biol Chem 288:29267–29280CrossRef Charvet CD, Saadane A, Wang M et al (2013) Pretreatment with pyridoxamine mitigates isolevuglandin-associated retinal effects in mice exposed to bright light. J Biol Chem 288:29267–29280CrossRef
26.
Zurück zum Zitat Mudd SH, Pool JR (1975) Labile methyl balance for normal humans on various dietary regimens. Metabolism 24:721–723CrossRef Mudd SH, Pool JR (1975) Labile methyl balance for normal humans on various dietary regimens. Metabolism 24:721–723CrossRef
27.
Zurück zum Zitat Gallagher D, Visser M, De Meersman RE et al (1997) Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol 83:229–239CrossRef Gallagher D, Visser M, De Meersman RE et al (1997) Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol 83:229–239CrossRef
28.
Zurück zum Zitat Verhoef P, Meleady R, Daly LE et al (1999) Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group. Eur Heart J 20:1234–1244CrossRef Verhoef P, Meleady R, Daly LE et al (1999) Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group. Eur Heart J 20:1234–1244CrossRef
29.
Zurück zum Zitat Chen JY, Tsai YW, Chen SY et al (2015) The association of leptin and homocysteine with renal function impairment in a population of Taiwanese adults. Clin Nutr 34:943–950CrossRef Chen JY, Tsai YW, Chen SY et al (2015) The association of leptin and homocysteine with renal function impairment in a population of Taiwanese adults. Clin Nutr 34:943–950CrossRef
30.
Zurück zum Zitat Nygård O, Vollset SE, Refsum H et al (1995) Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 274:1526–1533CrossRef Nygård O, Vollset SE, Refsum H et al (1995) Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 274:1526–1533CrossRef
31.
Zurück zum Zitat Abe T, Kearns CF, Fukunaga T (2003) Sex differences in whole body skeletal muscle mass measured by magnetic resonance imaging and its distribution in young Japanese adults. Br J Sports Med 37:436–440CrossRef Abe T, Kearns CF, Fukunaga T (2003) Sex differences in whole body skeletal muscle mass measured by magnetic resonance imaging and its distribution in young Japanese adults. Br J Sports Med 37:436–440CrossRef
32.
Zurück zum Zitat Cartee GD, Hepple RT, Bamman MM, Zierath JR (2016) Exercise promotes healthy aging of skeletal muscle. Cell Metab 23:1034–1047CrossRef Cartee GD, Hepple RT, Bamman MM, Zierath JR (2016) Exercise promotes healthy aging of skeletal muscle. Cell Metab 23:1034–1047CrossRef
33.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Cruickshanks KJ (1994) Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 154:2169–2178CrossRef Klein R, Klein BE, Moss SE, Cruickshanks KJ (1994) Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 154:2169–2178CrossRef
34.
Zurück zum Zitat Kawasaki R, Tanaka S, Tanaka S et al (2011) Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes Complications Study (JDCS). Diabetologia 54:2288–2294CrossRef Kawasaki R, Tanaka S, Tanaka S et al (2011) Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes Complications Study (JDCS). Diabetologia 54:2288–2294CrossRef
35.
Zurück zum Zitat Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813–823CrossRef Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813–823CrossRef
36.
Zurück zum Zitat Johansson L, Solvoll K, Bjørneboe GE, Drevon CA (1998) Under- and overreporting of energy intake related to weight status and lifestyle in a nationwide sample. Am J Clin Nutr 68:266–274CrossRef Johansson L, Solvoll K, Bjørneboe GE, Drevon CA (1998) Under- and overreporting of energy intake related to weight status and lifestyle in a nationwide sample. Am J Clin Nutr 68:266–274CrossRef
37.
Zurück zum Zitat Horikawa C, Yoshimura Y, Kamada C et al (2014) Dietary intake in Japanese patients with type 2 diabetes: analysis from Japan Diabetes Complications Study. J Diabetes Investig 5:176–187CrossRef Horikawa C, Yoshimura Y, Kamada C et al (2014) Dietary intake in Japanese patients with type 2 diabetes: analysis from Japan Diabetes Complications Study. J Diabetes Investig 5:176–187CrossRef
38.
Zurück zum Zitat Sone H, Ito H, Ohashi Y et al (2003) Obesity and type 2 diabetes in Japanese patients. Lancet 361:85CrossRef Sone H, Ito H, Ohashi Y et al (2003) Obesity and type 2 diabetes in Japanese patients. Lancet 361:85CrossRef
39.
Zurück zum Zitat Martin GS, Tapsell LC, Batterham MJ, Russell KG (2002) Relative bias in diet history measurements: a quality control technique for dietary intervention trials. Public Health Nutr 5:537–545CrossRef Martin GS, Tapsell LC, Batterham MJ, Russell KG (2002) Relative bias in diet history measurements: a quality control technique for dietary intervention trials. Public Health Nutr 5:537–545CrossRef
40.
Zurück zum Zitat Ekinci EI, Clarke S, Thomas MC et al (2011) Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 34:703–709CrossRef Ekinci EI, Clarke S, Thomas MC et al (2011) Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 34:703–709CrossRef
Metadaten
Titel
Vitamin B6 intake and incidence of diabetic retinopathy in Japanese patients with type 2 diabetes: analysis of data from the Japan Diabetes Complications Study (JDCS)
verfasst von
Chika Horikawa
Rei Aida
Chiemi Kamada
Kazuya Fujihara
Shiro Tanaka
Sachiko Tanaka
Atsushi Araki
Yukio Yoshimura
Tatsumi Moriya
Yasuo Akanuma
Hirohito Sone
Japan Diabetes Complications Study Group
Publikationsdatum
31.05.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 4/2020
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-019-02014-4

Weitere Artikel der Ausgabe 4/2020

European Journal of Nutrition 4/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.